Last updated on December 2005

Random Trial for Elderly Patients With NSCLC


Brief description of study

1. Recently a radomized trial of vinorelbine versus best supportive care in patients at 70 years of age or older demonstrated a definite improvement in overall survival rate and quality of life with chemotherapy. 2. The role of combination therapy containing the platinum compound, which is the standard therapy for the young patients is still vague. 3. Gemcitabine and carboplatin have favorable toxicity profile.

Clinical Study Identifier: NCT00265694

Contact Investigators or Research Sites near you

Start Over

Inje University Sanggyepaik Hospital

Seoul, Korea, Republic of
7.6miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.